Therefore, it is clear that the interaction of CSs with NKA and the subsequent activation of signaling cascades has an antitumor effect, but the mechanism of action differs not only between noncancerous vs. cancerous cells but also among various cancer types. The gene discussed is TAC1; the disease is cancer.